novo nordisk weight loss - Search News

News

Novo Nordisk, Wegovy drugs

The Wall Street Journal on MSN · 23h

Novo Nordisk’s Wegovy Weight-Loss Drug Sales Surge Despite Copycat Issues

Second-quarter sales of the blockbuster drug soared 67% on year, despite millions of U.S. patients using generic unbranded versions of the drug.

Reuters on MSN · 1d

Novo Nordisk's weight loss challenge in five charts

Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market capitalization since mid last year as competition from U.S. rival Eli Lilly and Co (LLY.N) and copycat rivals has hardened.

Seeking Alpha on MSN · 1d

Novo Nordisk expands legal battle over compounded weight loss drugs

Novo Nordisk (NVO) files additional court cases against vendors selling cheaper semaglutide knockoffs. Read more here.

Fierce Biotech21h

Novo Nordisk drops 2 obesity drugs as part of major pipeline clearout

Novo Nordisk has abandoned another GLP-1/GIP co-agonist and CB1 receptor as part of a significant pipeline clearout that ...

3hon MSN

Novo Nordisk (NVO) Gets Downgraded to Neutral from Buy at UBS

Novo Nordisk A/S (NYSE:NVO) is one of the top NYSE stocks with the highest upside potential. On August 5, UBS downgraded Novo ...

1don MSN

Novo Nordisk Stock Catches a Downgrade. The Eli Lilly Threat Is Just One Reason.

Novo Nordisk stock was downgraded to Neutral from Buy by UBS analysts, who cited the threat posed by Eli Lilly as just one ...

1don MSN

Why Novo Nordisk Stock Is Down Again Today

Weston's downgrade still values Novo Nordisk stock above its current share price of $47 and change, however. Moreover, Novo ...

6don MSN

Can Novo Nordisk’s New CEO Stop Rivals From Taking Over the Anti-Obesity Market?

Danish leader will face a challenging landscape among competitors ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results